Presented by PharmaVendor

• Another catapult today. Human Genome Sciences (HGSI) saw its stock soar almost 30% on positive data from its Benlysta trial in patients with lupus. There’s news all over the place, so I’ll just let you guys choose the link! [Google News]

• GSK in cardiovascular deal with Xenon Pharmaceuticals. [BioSpace]

• CSL likely to beat GSK, Sanofi to market with swine flu vaccine. [Bloomberg]

• Transcept Pharmaceuticals (TSPT) sees a likely 3 month PDUFA delay. [Reuters]

• Wyeth vaccine Prevenar gaining momentum. [PRNewswire]

• Sanofi fends off acquisition rumors. [reuters]

• Finally, Opko Health is making an investment in antibody developer Sorrento Therapeutics. [BizJournals]

Anonymous Tip? Comments? Contact us: hr AT iguanabio DOT com

Related Posts